FDA Approves 2nd Opioid Reversal Drug for Over-The-Counter Use

The nasal spray will be available prescription-free by next year. The Food and Drug Administration (FDA) recently approved the opioid overdose reversal drug RiVive for over-the-counter sale, making…

Read More

FDA Approves Gene Therapy for Hemophilia A

Severe cases of the bleeding disorder can be life-threatening. The U.S. Food and Drug Administration (FDA) has granted approval for Roctavian, gene therapy for adults with severe hemophilia…

Read More

FTC and FDA Warn Companies Selling Copycat Delta-8 THC

The joint effort by federal agencies seeks to protect consumers from the potentially harmful ingredient. The Federal Trade Commissioner (FTC) and the Food and Drug Administration (FDA) have…

Read More

FDA Fully Approves Alzheimer’s Drug Leqembi

This traditional approval follows previously fast-tracked authorization. The Food and Drug Administration (FDA) has approved Leqembi for the treatment of Alzheimer’s disease. The FDA included a safety warning…

Read More

FDA Approves First Cell Therapy for Type 1 Diabetes

The treatment was developed to address patients struggling to maintain target blood glucose levels. The U.S. Food and Drug Administration recently granted approval to CellTrans, Inc. for Lantidra.…

Read More

FDA Approves Gene Therapy for Muscular Dystrophy in Children

Treatment is intended for kids with a confirmed mutation of the DMD gene. The U.S. Food and Drug Administration (FDA) recently approved Elevidys, the first gene therapy for…

Read More

U.S. Military Adds Blue Lotus to Banned Substance List

FDA does not regulate the psychotropic drug, available via e-cigarettes or vaping. The Department of Defense has added blue lotus, a drug from the Egyptian flower Nymphaea caerulea,…

Read More

USDA Approves Lab-Grown Chicken Meat

FDA already authorized products as safe to consume. The U.S. Department of Agriculture’s Food Safety and Inspection Service has given the approval for a meat product grown directly…

Read More

FDA Releases Guidelines on Safeguarding Tattoo Ink from Microbes

The guidance is open to public comment for 90 days. The U.S. Food and Drug Administration (FDA) has released preliminary guidelines to help tattoo ink manufacturers and distributors…

Read More

FDA Proposes Updates to Clinical Trials

The drafted guidance would modernize the trials to be more efficient and reliable. The U.S. Food and Drug Administration (FDA) has released a draft guidance that provides updated…

Read More

Back to top
FE3